Skip to main content
SpringerLink
Log in

Retinales kapilläres Hämangioblastom im makulopapillären Bündel

Retinal capillary hemangioblastoma in the maculopapillary bundle

  • Kasuistiken
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Albinana V, Escribano RMJ, Soler I et al (2017) Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. Orphanet J Rare Dis 12:122

    Article  Google Scholar 

  2. Bernstein PS, Horn RS (2008) Verteporfin photodynamic therapy involving the optic nerve for peripapillary choroidal neovascularization. Retina 28:81–84

    Article  Google Scholar 

  3. Binderup MLM, Stendell AS, Galanakis M et al (2018) Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease. Br J Ophthalmol 102:942–947

    Article  Google Scholar 

  4. Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 119(2):198–207

    CAS  PubMed  Google Scholar 

  5. Hernández-Martínez P, Gallego-Pinazo R, Dolz-Marco R et al (2015) Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma. Arch Soc Esp Oftalmol 90:399–401

    Article  Google Scholar 

  6. Karimi S, Nikkhah H, Ahmadieh H et al (2020) Intravitreal injection of propranolol for the treatment of retinal capillary hemangioma in a case of von Hippel-Lindau. Retin Cases Brief Rep 14:305–309

    PubMed  Google Scholar 

  7. Reinke MH, Canakis C, Husain D et al (1999) Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 106:1915–1923

    Article  CAS  Google Scholar 

  8. Schnurrbusch UE, Jochmann C, Einbock W et al (2005) Complications after photodynamic therapy. Arch Ophthalmol 123:1347–1350

    Article  Google Scholar 

  9. Singh AD, Nouri M, Shields CL et al (2002) Treatment of retinal capillary hemangioma. Ophthalmology 109:1799–1806

    Article  Google Scholar 

  10. Slim E, Antoun J, Kourie HR et al (2014) Intravitreal bevacizumab for retinal capillary hemangioblastoma: a case series and literature review. Can J Ophthalmol 49:450–457

    Article  Google Scholar 

  11. Stattin M, Kralinger M, Haas G et al (2014) Photodynamic therapy for retinal capillary hemangioblastoma. Can J Ophthalmol 49:e32–e35

    Article  Google Scholar 

  12. Van Overdam KA, Missotten T, Kilic E et al (2017) Early surgical treatment of retinal hemangioblastomas. Acta Ophthalmol 95:97–102

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augenklinik Sulzbach, Knappschaftsklinikum Saar, An der Klinik 10, 66280, Sulzbach/Saar, Deutschland

    Salaheddin El Mourad, Sami Al-Nawaiseh, Peter Szurman & Boris V. Stanzel

  2. Klaus Heimann Eye Research Institute, An der Klinik 10, 66280, Sulzbach/Saar, Deutschland

    Peter Szurman & Boris V. Stanzel

Authors
  1. Salaheddin El Mourad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sami Al-Nawaiseh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Szurman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Boris V. Stanzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Boris V. Stanzel.

Ethics declarations

Interessenkonflikt

S. El Mourad, S. Al-Nawaiseh, P. Szurman und B.V. Stanzel geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El Mourad, S., Al-Nawaiseh, S., Szurman, P. et al. Retinales kapilläres Hämangioblastom im makulopapillären Bündel. Ophthalmologe 119, 190–194 (2022). https://doi.org/10.1007/s00347-021-01331-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-021-01331-6

Search

Navigation